Patents

US 12703864 B2: Vectors and compositions for treating hemoglobinopathies

Granted
2026-08-11
Filed
2022-01-28 application 17587999
Type
Utility · 11 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The invention provides improved gene therapy vectors, compositions, and methods.

Source: PTBLXML, file of 2026-08-11 (ipgb20260811.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Children's Medical Center Corporation 717 patentsUS company or organizationBoston, MATHE CHILDREN'S MEDICAL CENTER CORPORATION State business registration FUZZY medium confidence: same name (legal endings aside) and statePTBLXML, file of 2026-08-11

Inventors

InventorPlacePatentsPerson pageSource
Gabor VeresNovato, CA6PTBLXML, file of 2026-08-11
David A. WilliamsDover, MAPTBLXML, file of 2026-08-11

CPC categories

SubclassCategoryFirst groupSource
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N15/113PTBLXML, file of 2026-08-11
A61KPreparations for medical, dental or toiletry purposesA61K9/0019PTBLXML, file of 2026-08-11

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.